Collateral effect of the COVID-19 pandemic on cardiology service provision and cardiovascular mortality in a population-based study: COVID-COR-LT

Čelutkienė, Jelena; Cerlinskaite-Bajore, Kamile; Bajoras, Vilhelmas; Višinskienė, Rasa; Lizaitis, Mindaugas; Budrys, Povilas; Buivydas, Romualdas; Gurevičius, Romualdas; Šerpytis, Pranas; Davidavičius, Giedrius

doi:10.1007/s00392-022-02033-y

Cited by 5 publications

(4 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Third, adults in U.S. who are under Medicare age (generally under 65) have unequal access to health insurance, which may affect the access to health care and thus lead to an increase in mortality. Meanwhile, the elderly with cardiovascular diseases may actively seek outpatient care, whereas healthier young people may delay seeking care ( 37 ). In addition, the elderly still experienced the greatest absolute mortality and excess deaths remained persistent even in 2023 compared to the other two groups.…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

Song,

Guo,

et al. 2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

BackgroundAn increase in deaths has been perceived during the pandemic, which cannot be explained only by COVID-19. The actual number of deaths far exceeds the recorded data on deaths directly related to SARS-CoV-2 infection. Data from early and short-lived pandemic studies show a dramatic shift in cardiovascular mortality. Grounded in the post-pandemic era, macroscopic big data on cardiovascular mortality during the pandemic need to be further reviewed and studied, which is crucial for cardiovascular disease prevention and control.MethodsWe retrieved and collected data associated with cardiovascular disease mortality from the National Vital Statistic System from the Center for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) platform based on the ICD-10 codes. We applied regression analysis to characterize overall cardiovascular disease mortality trends from 2010 to 2023 and built a time series model to predict mortality for 2020–2023 based on mortality data from 2010 to 2019 in order to affirm the existence of the excess deaths by evaluating observed vs. predicted mortality. We also conducted subgroup analyses by sex, age and race/ethnicity for the purpose of obtaining more specific sociodemographic information.ResultsAll-cause age-standardised mortality rates (ASMRs) for CVD dramatically increased between 2019 and 2021[annual percentage change (APC) 11.27%, p < 0.01], and then decreased in the following 2021–2023(APC: −7.0%, p < 0.01). Subgroup analyses found that the ASMR change was most pronounced in Alaska Indians/Native American people (APC: 16.5% in 2019–2021, −12.5% in 2021–2023, both p < 0.01), Hispanics (APC: 12.1% in 2019–2021, −12.2% in 2021–2023, both p < 0.05) and non-Hispanic Black people (APC:11.8% in 2019–2021, −10.3% in 2021–2023, both p < 0.01)whether during the increasing or declining phase. Similarly, the ASMR change was particularly dramatic for the 25–44 age group (APC:19.8% in 2019–2021, −15.4% in 2021–2023, both p < 0.01) and males (APC: 11.5% in 2019–2021, −7.6% in 2021–2023, both p < 0.01). By the end of 2023, the proportion of COVID-related excess death remained high among the elderly (22.4%), males (42.8%) and Alaska Indians/Native American people(39.7%). In addition, we did not find the presence of excess deaths in the young (25–44) and middle-aged cohort (45–64) in 2023, while excess deaths remained persistent in the elderly.ConclusionsAll-cause ASMRs for CVD increased notably during the initial two years of the COVID-19 pandemic and then witnessed a decline in 2021–2023. The cohorts (the young, males and minorities) with the steepest rise in mortality decreased at the fastest rate instead. Previous initiatives to promote cardiovascular health were effective, but further research on cardiovascular healthcare for the elderly and racial disparities should be attached to priority considering the presence of sociodemographic differences in CVD death.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

Song,

Guo,

et al. 2024

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…In addition, a survey of health care workers from 64 countries found that most felt that people with TB and HIV faced greater challenges accessing health services during the pandemic, with reduced mobility and health facility closures frequently stated as reasons [19]. While the pandemic's effects on TB-associated mortality have not yet become clear [20], increased deaths from cardiovascular disease [21,22], neonatal deaths [23], and deaths attributable to delays in accessing medical care during the pandemic [24] have been reported in various countries. Thus, it is an important lesson for future public health emergencies that changes to health system priorities and procedures should consider who may be harmed as well as who will benefit.…”

Section: Discussionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on patients’ experiences obtaining a tuberculosis diagnosis in Peru: a mixed-methods study

et al. 2022

View full text Add to dashboard Cite

Background The COVID-19 pandemic disrupted TB services worldwide, leading to diagnostic delays. There have been few published reports describing how the pandemic affected people’s pathway to diagnosis from their own perspectives. We sought to evaluate the impact on the pandemic on people’s experiences obtaining a TB diagnosis. Methods We performed a mixed-methods study, enrolling newly diagnosed TB patients from 12 health centers in Lima, Peru. We used structured surveys to quantify diagnostic delay, defined as the time between symptom onset and diagnosis, and in-depth interviews to understand the ways in which the pandemic affected the pathway to care. We compared diagnostic delay between patients enrolled during the first year of the pandemic to those diagnosed after using a Wilcoxon rank-sum test. We used an inductive content analysis approach to analyze interview content related to the pandemic. Results We enrolled 51 patients during November 2020–April 2021 (during the first year of the pandemic) and 49 patients during October 2021–February 2022. Median diagnostic delay was longer for patients diagnosed during the first year of the pandemic (median 15 [IQR 5–26] weeks compared to 6 [IQR 3–18] weeks, p = 0.027). Qualitative analysis of 26 interviews revealed that the pandemic affected participants’ care-seeking behavior and their ability to access to TB diagnostic services, particularly for those diagnosed in the first year of the pandemic. Many participants initially had their symptoms attributed to COVID-19, resulting in delayed TB evaluation and additional costs for COVID-19 treatment. Conclusions The COVID-19 pandemic impacted multiple steps in the pathway to care for TB patients in Lima, causing delays in TB diagnosis. These findings demonstrate how the shifting of health care resources to prioritize COVID-19 can lead to collateral damage for people with TB and other conditions.

show abstract

“…The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic carries a potential increase in the number of patients with cardiovascular (CV) diseases and in the individual risk of atherosclerotic cardiovascular disease (ASCVD). This may be the result of complications from the coronavirus infection itself [1], adverse lifestyle changes during the lockdowns and quarantine periods [2][3][4][5], and limitations in preventive, diagnostic, and therapeutic procedures due to changes in the organization of healthcare [6,7].…”

Section: Introductionmentioning

confidence: 99%

“…However, the pandemic's effects on the population's health are not limited to the coronavirus infection. The restrictive epidemiological limitations and the reorganization of health care contributed to a decline in the availability of outpatient and inpatient treatment, a reduction in the effectiveness of primary and secondary prevention of CV diseases, and an increase in CV mortality [6,7]. In addition, epidemiological studies conducted on the Polish population indicate the limitation of physical activity in 43% of people [4]; increased food and snacks consumption in 34%-43% and 52% of people [4,5], respectively; and weight gain in 30% of respondents [5], which was secondary to isolation during the pandemic.…”

Section: Introductionmentioning

confidence: 99%

Cardiac status and atherosclerotic cardiovascular risk of convalescents after COVID-19 in Poland

Loboda¹,

Sarecka-Hujar²,

Wilczek³

et al. 2023

Polish Archives of Internal Medicine

View full text Add to dashboard Cite

The coronavirus disease 2019 (COVID-19) pandemic carried cardiac complications, unfavorable lifestyle changes during the lockdowns, and limitations in preventive, diagnostic, and therapeutic procedures. We assessed the history of cardiac complications, exercise capacity, blood pressure control, echocardiography, 24-hour electrocardiogram Holter recording, and laboratory tests (i.e., cholesterol, fasting glucose, creatinine) of the convalescent group at an average of four months after infection. In addition, we estimated the 10-year risk of fatal and non-fatal atherosclerotic cardiovascular disease events (i.e., myocardial infarction and stroke) according to the Systemic Coronary Risk Estimation 2 (SCORE2) algorithm. Data collected after several months of recovery indicate a relatively small number of cardiac problems that could be associated with a history of COVID-19 in both sexes, whereas a high underlying risk of atherosclerosis-related diseases, especially in men. Therefore, physician evaluation of COVID-19 convalescents should also include an assessment and correction of atherosclerosis risk factors.

show abstract

Collateral effect of the COVID-19 pandemic on cardiology service provision and cardiovascular mortality in a population-based study: COVID-COR-LT

Cited by 5 publications

References 22 publications

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

Impact of the COVID-19 pandemic on cardiovascular mortality and contrast analysis within subgroups

The impact of the COVID-19 pandemic on patients’ experiences obtaining a tuberculosis diagnosis in Peru: a mixed-methods study

Cardiac status and atherosclerotic cardiovascular risk of convalescents after COVID-19 in Poland

Contact Info

Product

Resources

About